Your Location:Home >Products >Fine Chemicals >1094-61-7
 
                                                            
                                                        
Purity:99%
β-Nicotinamide Mononucleotide (“NMN” and “β-NMN”), an Anti-Aging Candidate Compound, Is Retained in the Body for Longer than Nicotinamide in Rats and it is a NAD+intermediate. β-Nicotinamide mononucleotide (NMN) has been widely used as a nutraceutical for self-medication. NMN and NR have been suggested to bind to ACE2 and IMPDH, along with SARS-CoV-2 viral proteins (Spro, Mpro, PLpro, RdRp) by molecular docking and dynamics simulations, suggesting a potential therapeutic effect of NMN and NR in the treatment of COVID-19.
InChI:InChI=1/C11H15N2O8P/c12-10(16)6-2-1-3-13(4-6)11-9(15)8(14)7(21-11)5-20-22(17,18)19/h1-4,7-9,11,14-15H,5H2,(H3-,12,16,17,18,19)/t7-,8-,9-,11-/m1/s1
These foundational data that were obtained using a pharmaceutical-grade β Nicotinamide mononucleotide (NMN), standardized sample collection, and validated liquid chromatography–tandem mass spectrometry assays, should facilitate design of efficacy trials in disease conditions.
In animal studies, β-nicotinamide mononucleotide (NMN) supplementation increases nicotinamide adenine dinucleotide (NAD) concentrations and improves healthspan and lifespan with great safety. The primary objective was to evaluate blood NAD concentration with dose-dependent regimens.

NAD


nicotinamide mononucleotide


adenosine 5'-diphosphate


adenosine
| Conditions | Yield | 
|---|---|
| With    water; zirconium(IV) oxide;      at 80 ℃; for 48h;  | 

3-carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium (β-D-nicotinamide riboside)


nicotinamide mononucleotide
| Conditions | Yield | 
|---|---|
| With    trimethyl phosphite; trichlorophosphate;      at 0 ℃; for 12h; Inert atmosphere;  | 88.27% | 
| 3-carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium (β-D-nicotinamide riboside);  With    Sodium trimetaphosphate; sodium hydroxide;     In   water;   at 30 ℃; for 4h; pH=9;  With    hydrogenchloride;     In   water;   at 10 ℃; Reagent/catalyst;  | 68% | 
| With    nitromethane; water; trichlorophosphate;       | |
| With    trichlorophosphate;       | |
| With    trimethyl phosphite; trichlorophosphate;      at -10 - -7 ℃; for 24h; Temperature;  | 10 g | 
| Multi-step reaction with 2 steps  1: pyridine / acetonitrile / 12 h / 0 - 5 °C 2: platinum(IV) oxide; hydrogen / deuteromethanol / 12 h With    pyridine; platinum(IV) oxide; hydrogen;     In   deuteromethanol; acetonitrile;    | 

3-carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium (β-D-nicotinamide riboside)

nicotinamide

5-phosphoribosyl-1-pyrophosphate

NAD

4'-(3-

4'-(6-

nicotinamide

C27H42N9O17P3
Direct Factory Supply Top Purity Cosmetics NMN 1094-61-7, Wholesale β-Nicotinamide Mononucleotide 1094-61-7 In Stock, In Bulk Supply
CAS:987-65-5
CAS:72804-96-7
CAS:25168-73-4
CAS:2094-72-6